Cloverleaf Bio
Biotechnology
Cloverleaf Bio is an RNA therapeutics company developing engineered tRNA-based therapeutics for cancer. A Yale University spinout headquartered in New Haven, Connecticut, its lead program CLB-001 targets hepatocellular carcinoma and raised a $33M seed round in September 2026.
- CLB-001 (inhibitory tRNA therapeutic targeting hepatocellular carcinoma)
- Antibody-tRNA conjugate (ATC) for colorectal cancer
Open roles at Cloverleaf Bio
3 matching roles
Unspecified
Boston, Massachusetts, United States
Full-time
Salary unavailable
Posted 2 years ago
Source: Breezy HR
Unspecified
Boston, Massachusetts, United States
Full-time
Salary unavailable
Posted 2 years ago
Source: Breezy HR
Unspecified
Boston, Massachusetts, United States
Full-time
Salary unavailable
Posted 2 years ago
Source: Breezy HR
Showing 3 of 3 roles